Veterinary Medicines

Nobilis CAV P4

Authorised
  • Chicken anaemia virus, strain 26P4, Live
Download as PDF

Product identification

Medicine name:
Nobilis CAV P4
Nobilis CAV P4 Lyofilisaat en oplosmiddel voor suspensie voor injectie
Nobilis CAV P4 Lyophilisat et solvant pour suspension injectable
Nobilis CAV P4 Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
  • Chicken anaemia virus, strain 26P4, Live
Target species:
  • Chicken
Route of administration:
  • Wing-web-stab use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain 26P4, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Wing-web-stab use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Cardboard box with 10 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 10 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule.
  • Cardboard box with 10 x 1000 doses of vaccine - Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 1000 doses Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/8659/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • Germany
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/11/2025
Download
French (PDF)
Published on: 28/11/2025
Download
German (PDF)
Published on: 28/11/2025
Download